genOway Société anonyme (EPA:ALGEN)
2.410
-0.030 (-1.23%)
Aug 3, 2026, 2:04 PM CET
genOway Société anonyme Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.55 | 4.95 | 4.26 | 4.88 | 5.61 |
Short-Term Investments | 6.5 | - | - | - | - |
Cash & Short-Term Investments | 7.05 | 4.95 | 4.26 | 4.88 | 5.61 |
Cash Growth | 42.41% | 16.24% | -12.69% | -12.94% | 106.06% |
Accounts Receivable | 8.88 | 6.35 | 5.12 | 7.79 | 6.31 |
Other Receivables | 5.62 | 4.82 | 7.13 | 5.79 | 6.19 |
Total Trade Receivables | 14.5 | 11.16 | 12.26 | 13.59 | 12.5 |
Inventory | 0.99 | 1.09 | 0.98 | 1.19 | 0.98 |
Other Current Assets | 0.35 | 0.25 | 0.23 | 0.17 | 0.25 |
Total Current Assets | 22.9 | 17.45 | 17.73 | 19.82 | 19.33 |
Net Property, Plant & Equipment | 12.51 | 5.56 | 5.88 | 6.67 | 7.17 |
Other Intangible Assets | 6.36 | 5.58 | 5.46 | 5.33 | 5.25 |
Goodwill | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Long-Term Investments | 3.11 | 2.71 | 2.25 | 0.58 | 0.55 |
Other Long-Term Assets | 0.28 | 0.29 | 0.33 | 0.33 | 0.16 |
Total Assets | 45.35 | 31.8 | 31.84 | 32.92 | 32.66 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.81 | 2.89 | 2.58 | 2.62 | 2.22 |
Accrued Expenses | 2.06 | 2.57 | 2.33 | 1.87 | 1.75 |
Short-Term Debt | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
Unearned Revenue | 0.67 | 1.12 | 1.54 | 2.05 | 2.06 |
Other Current Liabilities | 0.8 | 0.78 | 0.44 | 0.59 | 0.66 |
Total Current Liabilities | 6.34 | 7.36 | 6.9 | 7.13 | 6.69 |
Long-Term Debt | 13.76 | 5.57 | 7.22 | 9.04 | 10.82 |
Other Long-Term Liabilities | 0.28 | 0.29 | 0.33 | 0.59 | 0.43 |
Total Long-Term Liabilities | 14.04 | 5.87 | 7.55 | 9.63 | 11.25 |
Total Liabilities | 20.1 | 12.93 | 14.13 | 16.17 | 17.51 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7.48 | 5.69 | 5.56 | 5.45 | 5.45 |
Additional Paid-in Capital | 13.9 | 9.04 | 9.14 | 9.22 | 9.22 |
Accumulated Other Comprehensive Income | - | 0.49 | 0.96 | 1.43 | 1.41 |
Retained Earnings | 3.6 | 2.67 | 0.84 | -0.73 | -1.51 |
Total Common Shareholders' Equity | 24.97 | 17.9 | 16.5 | 15.37 | 14.57 |
Minority Interest | - | 0.68 | 0.88 | 0.8 | 0.15 |
Shareholders' Equity | 24.97 | 18.57 | 17.38 | 16.17 | 14.72 |
Total Liabilities & Equity | 45.35 | 31.8 | 31.84 | 32.92 | 32.66 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13.77 | 5.58 | 7.23 | 9.05 | 10.83 |
Net Cash (Debt) | -6.72 | -0.62 | -2.97 | -4.17 | -5.22 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.54 | -0.07 | -0.32 | -0.46 | -0.57 |
Book Value | 24.97 | 17.9 | 16.5 | 15.37 | 14.57 |
Book Value Per Share | 2.00 | 1.89 | 1.78 | 1.69 | 1.60 |
Tangible Book Value | 18.42 | 12.12 | 10.85 | 9.84 | 9.12 |
Tangible Book Value Per Share | 1.48 | 1.28 | 1.17 | 1.08 | 1.00 |